Literature DB >> 8114276

[Penetration of potassium clavulanate/ticarcillin sodium into cerebrospinal fluid in neurosurgical patients].

H Nakagawa1, M Yamada, K Tokiyoshi, Y Miyawaki, T Kanayama.   

Abstract

Concentrations of potassium clavulanate (CVA) and ticarcillin sodium (TIPC) in the plasma and cerebrospinal fluid (CSF) of patients after neurosurgical intervention were determined at various times after a 1-hour drip infusion (3.2-g dose). Patients whose blood-brain barriers were supposed to be maintained in almost a normal condition were selected. CSF was obtained through a catheter placed in the anterior horn of the lateral ventricle in all the patients. Maximum plasma levels (micrograms/ml) of 57.6 to 384.0 with an average of 169.7 (TIPC) and 0.41 to 26.2 with an average of 6.1 (CVA) were achieved at the termination of infusion. The maximum CSF levels (micrograms/ml) were 0.61 to 18.8 (TIPC) and 0.1 to 6.81 (CVA) with mean values of 4.5 and 1.2, respectively. Plasma half lives (T1/2) (minute) were 24 to 93 (TIPC) and 32 to 227 with mean values of 58 and 127, respectively. The mean values of the CSF half lives (minute) were 237 (TIPC) and 113 (CVA). The ratios (%) of CSF levels to plasma levels in maximum concentration (Cmax), AUC (area under concentration curve) and half life (T1/2) were calculated. Cmax ratios were 0.2 to 29.2 (TIPC) and 1.4 to 69.8 (CVA) with mean values of 4.4 and 22.8, respectively. AUC ratios were 0.3 to 23.5 (TIPC) and 1.1 to 70.2 (CVA) with mean values of 4.3 and 22.4, respectively. T1/2 ratios were 1.3 to 18 (TIPC) and 1.1 to 4.3 (CVA) with mean values of 5.5 and 2.3, respectively. These values indicate that CVA/TIPC may be classified into a group of antibiotics with good penetration into the CSF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114276

Source DB:  PubMed          Journal:  Jpn J Antibiot        ISSN: 0368-2781


  15 in total

1.  Clavulanic acid increases dopamine release in neuronal cells through a mechanism involving enhanced vesicle trafficking.

Authors:  Gina Chun Kost; Senthil Selvaraj; Young Bok Lee; Deog Joong Kim; Chang-Ho Ahn; Brij B Singh
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

2.  β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.

Authors:  Alqassem Y Hakami; Youssef Sari
Journal:  Neurosci Lett       Date:  2017-08-05       Impact factor: 3.046

3.  Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats.

Authors:  Mahnoush Kolahdouz; Faranak Jafari; Farahnaz Falanji; Samad Nazemi; Mohammad Mohammadzadeh; Mehdi Molavi; Bahareh Amin
Journal:  Neurochem Res       Date:  2021-04-12       Impact factor: 3.996

4.  Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.

Authors:  Sunil Goodwani; P S S Rao; Richard L Bell; Youssef Sari
Journal:  Brain Res       Date:  2015-07-10       Impact factor: 3.252

5.  β-lactamase inhibitors display anti-seizure properties in an invertebrate assay.

Authors:  S M Rawls; F Karaca; I Madhani; V Bhojani; R L Martinez; M Abou-Gharbia; R B Raffa
Journal:  Neuroscience       Date:  2010-06-23       Impact factor: 3.590

6.  Clavulanic acid inhibits MPP⁺-induced ROS generation and subsequent loss of dopaminergic cells.

Authors:  Gina Chun Kost; Senthil Selvaraj; Young Bok Lee; Deog Joong Kim; Chang-Ho Ahn; Brij B Singh
Journal:  Brain Res       Date:  2012-06-29       Impact factor: 3.252

7.  Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?

Authors:  Joseph A Schroeder; Nicholas G Tolman; Faye F McKenna; Kelly L Watkins; Sara M Passeri; Alexander H Hsu; Brittany R Shinn; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

Review 8.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

9.  Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice.

Authors:  Jae Kim; Joel John; Dianne Langford; Ellen Walker; Sara Ward; Scott M Rawls
Journal:  Amino Acids       Date:  2015-11-05       Impact factor: 3.520

10.  The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens.

Authors:  Helene L Philogene-Khalid; Mary F Morrison; Nune Darbinian; Michael E Selzer; Joseph Schroeder; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.